Previous 10 | Next 10 |
2023-04-26 00:15:28 ET Summary After bringing you the first quarter installment covering large-cap and mid-cap insider activity, today's article will focus on the latest insider activity within the small-cap range. We believe that insiders supply the market with high-quality infor...
MIAMI, April 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2023 after the close of the U.S. financial markets on Wednesday, May 3, 2023. OPKO’s senior management will provide a business ...
2023-03-31 14:13:06 ET Summary Merck & Co has more than 60 drugs and projects in clinical development, a robust balance sheet, and free cash flow. We believe earnings and revenue will continue to grow, driving the share price up perhaps 30% or more over the next 12 months. ...
2023-03-28 10:58:16 ET As an investor, there are various strategies that you can employ to maximize your returns in the stock market. For example, you’ve got a lot more to consider when it comes to penny stocks . Low-priced equities are prime candidates for high volatility and ri...
2023-03-23 13:57:11 ET Summary This month Florida-based OPKO Health announced it had entered into an agreement with pharma giant Merck to develop a vaccine for Epstein Barr Virus. Merck has paid OPKO $50m upfront and pledged >$850m in potential milestone payments to co-develop ...
MIAMI, March 09, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that it will hold an R&D Day event on March 20, 2023 beginning at 4:00 p.m. Eastern time. The two-hour virtual event will provide an opportunity to hear from OPKO executives about the ModeX Therapeut...
2023-03-08 16:34:00 ET Shares of drug and diagnostics company OPKO Health (NASDAQ: OPK) closed 8% higher Wednesday following news of a collaboration agreement with pharmaceutical giant Merck (NYSE: MRK) . While down from an intraday rally of more than 24%, the remaining gain...
2023-03-08 16:07:58 ET OPKO Health ( NASDAQ: OPK ) closed up 6.6% on Wednesday after signing a licensing deal with Merck to develop an Epstein-Barr virus vaccine together. The arrangement is between OPKO's ( OPK ) ModeX Therapeutics unit and Merck ( MRK ) for p...
2023-03-08 10:44:00 ET As savvy investors know, penny stocks can offer high returns if chosen wisely. These stocks, which trade for less than $5 per share, often represent small companies with high growth potential. But they also carry high risks due to their volatility and low liquidity. T...
2023-03-08 08:38:01 ET Opko Health's ( NASDAQ: OPK ) ModeX Therapeutics signed a worldwide license agreement with Merck ( NYSE: MRK ) to develop its preclinical Epstein-Barr Virus (EBV) vaccine candidate MDX-2201. EBV, also known as human herpesvirus 4, is a m...
News, Short Squeeze, Breakout and More Instantly...
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's common stock. Under the repurchase program, OPKO may repurchase shares of its common ...
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by OPKO’s profit share payments from Pfizer received pursuant to its license agreement relat...
NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner PR Newswire New Marketing Partner to Support the Expanded Sales of OPKO-Branded Products Throughout China on Additi...